1. Thrombocytosis in EPO-Treated Dialysis Patients May Be Mediated by EPO Rather Than Iron Deficiency 
Nosratola D. Vaziri, MD 
American Journal of Kidney Diseases 
Volume 53, Issue 5, Pages (May 2009)
DOI: /j.ajkd
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Effects of high doses of erythropoietin on platelet production, platelet activity, and potential risks of thromboembolism and cardiovascular disease. Abbreviations: [Ca2+]i, intracellular ionized calcium concentration; vWF, von Willebrand factor.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions